USPTO trademark

ARAMIRA

AllowedUSPTOWord markClass 5

"ARAMIRA" is a word mark owned by CG Oncology, Inc., filed at the USPTO on May 16, 2023. It has been allowed and covers class 5 (Pharmaceuticals).

View CG Oncology, Inc. portfolioGet this data via the API
Official USPTO record
ARAMIRA trademark as filed
As filed with the USPTO
Status
Allowed
Since March 20, 2026
Filed
May 16, 2023
Registered
Not yet
Expires
Not recorded
Application no.
97939152
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns ARAMIRA

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

CG Oncology, Inc.

CGON · Irvine, United States

8 trademarks in the portfolioView company

Representative

Perry J. Viscounty

Latham & Watkins LLP

Goods and services

What the mark covers

The products and services ARAMIRA is filed for, grouped by Nice class.

  • Pharmaceutical products for the treatment of cancer, pharmaceutical preparations and biological preparations for the treatment of cancer and immunological disorders; Biopharmaceuticals for the treatment of cancer, namely, antibodies, non-antibody proteins, blood and blood components, stem cells, hormones, blood factors, tumor necrosis factors; Chemical preparations for medical or pharmaceutical purposes, namely, for cancer treatment, oncology and immunotherapy for auto immune diseases; Pharmaceutical products, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Sou teas extension received
  2. Notice of approval of extension request e-mailed
  3. Sou extension 4 granted
  4. Sou extension 4 filed
  5. Sou teas extension received
  6. Notice of approval of extension request e-mailed
  7. Sou extension 3 granted
  8. Sou extension 3 filed
  9. Sou teas extension received
  10. Notice of approval of extension request e-mailed

10 earlier steps on the official record.

FAQ

About ARAMIRA

Who owns the trademark "ARAMIRA"?

The USPTO trademark "ARAMIRA" (application 97939152) is owned by CG Oncology, Inc.

What is the status of "ARAMIRA"?

Its status at the USPTO is: allowed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull ARAMIRA and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2bb6-4794-7632-bf23-3ad597be3739
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2bb6-4794-7632-bf23-3ad597be3739",
  "object": "trademark",
  "mark_text": "ARAMIRA",
  "status": {
    "primary": "pending",
    "stage": "allowed"
  },
  "office_code": "US",
  "application_number": "97939152",
  "filing_date": "2023-05-16",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "CG Oncology, Inc.",
      "entity_id": "ent_019eb70f-20f0-736a-805e-dea9ff413d49"
    }
  ]
}